Pay in 4 interest-free payments of $6.67 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Presented for research literature review only Oguchi M et al
Continue following Ozempic/GLP-1 trends here
Improved glycaemic control from Wegovy may actually reduce yeast infection risk over time in patients with diabetes
Phase 3 TRIUMPH-4 Results: The Latest Data (December 2025) The first Phase 3 results for Retatrutide came from the TRIUMPH-4 trial, announced by Eli Lilly on December 11, 2025
The GLP-1 market is moving fast
The drug is known generically as liraglutide, which the FDA says has been in short supply with certain other GLP-1 medications. This references the consistent shortages for drugs like semaglutides, known by brand names such as Ozempic and Wegovy, and tirzepatides, with brand names like Zepbound and Mounjaro
